Category: Covid-19

Page 819«..1020..818819820821..830840..»

Americans vote in primaries amid Covid-19 and mass protests – The Guardian

June 3, 2020

Eight states and Washington DC are holding primaries on Tuesday in the most widespread trial yet over whether America can safely hold an election amid the pandemic and unrest as days of protest over the police killings of African Americans continues.

Election officials, who have been encouraging people to vote by mail, already faced an enormous challenge in providing access to voting while protecting public health against Covid-19. Now, they face an additional challenge of conducting an election that guarantees people can vote without risking their physical safety and without police intimidation as curfews clash with voting hours.

One of the most closely watched states on Tuesday is Pennsylvania, a battleground state, where lawmakers are already seeing an unprecedented flood of requests for mail-in ballots. More than 1.8 million people have requested an absentee ballot so far; during the 2016 primary, just 84,000 people voted by mail.But some voters are still expected to cast a ballot in person, as well.

Pennsylvania law requires voters to return their mail-in ballots to the polls by 8pm on election day. But on Monday evening Pennsylvanias governor, Tom Wolf, a Democrat, extended the deadline for voters in six counties in the state to return their ballots, saying they could be counted if they were received in the next week and postmarked by Tuesday.

That came after concern that some voters in the state might be disenfranchised because officials could not get them ballots in time. In Delaware county, just outside Philadelphia, elections officials said Monday they were mailing 6,000 ballots, the day before the election. The county conceded there were 400 ballots that wont be mailed due to timing and staffing constraints.

In Philadelphia and Pittsburgh, election officials have severely limited in-person voting locations because of the coronavirus pandemic. In Philadelphia, officials are monitoring whether they will have to change any of those few locations because of the recent protests, according to the Philadelphia Inquirer. At at least one voting location in Philadelphia, there were long lines on Tuesday morning as poll workers set up voting machines.

Voting rights groups monitoring the elections throughout the country said they were fielding calls from voters reporting problems. In many states, voters reported not receiving mail-in ballot requests in time to vote.

By Tuesday afternoon, about 500 people in Pennsylvania had called in to an election protection hotline run by the groups, about half of the voters were seeking information about their polling location, Suzanne Almeida, the interim executive director of Common Cause Pennsylvania, a watchdog group, told reporters.

In Baltimore, which is holding a Democratic mayoral primary, some voters reported never receiving the ballots they requested, forcing them to go to the polls on election day.

It is unclear how the increased police presence from the protests will mesh with established polling place hours. In Washington DC, Mayor Muriel Bowser announced a 7pm curfew for Tuesday, but polls will be open until 8pm. As the curfew approached, there were still people in line who expected to wait for more than an hour. Bowser said Tuesday no one who was voting would be subject to the curfew.

But there was confusion in the city as the day went on.

Sherene Joseph was in line to vote at Hardy Middle School in the Georgetown neighborhood of DC just before curfew when a police car drove by twice used a loudspeaker to tell everyone they needed to go home. The announcement set off confusion, she said, and elections staff came out to talk to police and encouraged everyone to stay in line and a volunteer gave out I voted stickers for voters to show police.

It didnt happen again and the folks working there made it clear everyone in line that they would be able to vote, she wrote in an email.

Some voters in DC said they never received their ballots and there were still long lines across the city on Tuesday. Only 10 people at a time were allowed into voting locations to allow for social distancing, according to The Washington Post. One voter told the Washington Post he had been told he sent his application to the wrong email address, even though he sent it to the one he was instructed to. Another woman said she couldnt get help requesting a ballot online so she wouldnt vote.

In Philadelphia, there will be an 8.30pm curfew and polls will be open until 8pm. Larry Krasner, the Philadelphia district attorney, said on Monday no one will be arrested for going to vote in violation of the curfew.

But Almeida said there hasnt been clear guidance on protections for people who were still waiting to vote and poll workers who remained at voting sites beyond the curfew time.

She also noted Center City in Philadelphia had been shut down to traffic and was being heavily patrolled, which was obviously a detriment to voters trying to cast a ballot there. The Pennsylvania Convention Center, located in the area, is hosting voting for 18 districts on Tuesday.

Imposing a 6pm curfew on election day threatens to disenfranchise the very people marching to be heard, along with all Philadelphians, said Quentin Palfrey, chair of Voter Protection Corps, a voting advocacy group. We applaud district attorney Krasners clear statement that no voter will be arrested or prosecuted for going to vote, but no such assurances can overcome the suppressive impact of the curfew.

She also noted that one of the voting sites in Wilkinsburg, a borough that is majority African American just outside of Pittsburgh, was in a government building that shared space with the police. It meant that voters would have to wait in line with law enforcement nearby, which could be intimidating.

In addition to Washington DC and Pennsylvania, Tuesday is primary day in Indiana, Iowa, Maryland, Montana, New Mexico, Rhode Island and South Dakota.

Go here to read the rest:

Americans vote in primaries amid Covid-19 and mass protests - The Guardian

The Utah legislature’s COVID-19 commission to re-open votes to go to ‘green’ this weekend – fox13now.com

June 3, 2020

SALT LAKE CITY The Utah State Legislature's commission created to re-open the economy is recommending the state move to a "green" risk level for COVID-19 as early as this weekend, FOX 13 is told.

The Public Health and Economic Emergency Commission voted on Tuesday to move to the lowest risk level, which eliminates a lot of the health guidelines in place by the state's COVID-19 task force and the Utah Department of Health. But Senate President J. Stuart Adams, R-Layton, who sits on the commission, said there would be modifications -- including continuing strongly encouraging social distancing, the wearing of face masks and sanitization practices in businesses.

"Still the six-foot distancing in checkout lines, all the things were doing now but to have it be broader and opened for more businesses to allow our economy to go forward," Sen. Adams told FOX 13 in an interview.

Right now, Utah is in a "yellow" or low risk for novel coronavirus. Only Salt Lake City, Bluff and Mexican Hat are at an "orange" -- or moderate risk level -- because of a high number of cases. Sen. Adams conceded some parts of the state may not move to green or "new normal" right away.

"Theres probably parts of the state that arent ready. Summit, Wasatch County, maybe Salt Lake City, maybe West Valley, Magna. Maybe other areas of the state," Sen. Adams told FOX 13 in an interview. "These are data driven decisions and were seeing data that indicate that were showing the spread is not as prevalent as we see along the Wasatch Front. And we see hospital rates, hospital capacity we could absorb any type of spike that were looking at right now."

Utah has seen a strong uptick in COVID-19 cases in recent days. But the commission is focusing on impact to Utah's hospital system. Sen. Adams said it has not been overwhelmed, justifying the recommendation to move to the lowest risk level.

"The commissions actually looking at going to green because the numbers are good," Sen. Adams said.

The commission includes Major General Jefferson Burton, the acting director of Utah's Department of Health; Dr. Michael Good, the CEO of University of Utah Health; Brian Dunn of Steward Healthcare; as well as Derek Miller of the Salt Lake Chamber (who also chairs the governor's COVID-19 Economic Recovery Task Force); Brandy Grace of the Utah Association of Counties and Steve Starks of the Larry H. Miller Corporation. Legislative representatives include Sen. Adams; Senate Majority Whip Dan Hemmert, R-Orem; and House Majority Whip Mike Schultz.

"We are aware of the commissions recommendation to move areas to 'green' where the data support such a move. We review data on a weekly basis, and to this point have not recommended any areas move to 'green,'" the Utah Department of Health said in a statement to FOX 13.

The commission's recommendation will go to Governor Gary Herbert on Wednesday.

"We will review the recommendations from the Public Safety and Economic Emergency Commission and take them under careful consideration as we work to identify the best path forward to keep Utahns safe and informed," the governor's office told FOX 13.

See original here:

The Utah legislature's COVID-19 commission to re-open votes to go to 'green' this weekend - fox13now.com

Army vaccine researchers are preparing for the possibility of new COVID-19 strains – ArmyTimes.com

June 3, 2020

Army medical experts involved in testing COVID-19 vaccine candidates developed by outside laboratories are also working to develop their own vaccine, one that can give them the building blocks to combat future strains of the virus if mutations arise.

The first few vaccines being queued up for what the White House recently dubbed Operation Warp Speed includes those by the companies Moderna, AstraZeneca and Johnson & Johnson, Army researchers involved in the project said during a telephone call with reporters Tuesday.

Modernas candidate, for instance, is very, very likely to be the first major vaccine to be tested in large scale, said Nelson Michael, director of the Center for Infectious Disease Research at Walter Reed Army Institute of Research.

But Army researchers are developing another vaccine, added Kayvon Modjarrad, the institutes director of emerging infectious diseases. Their vaccine is being designed with a long-term approach to combating new strains of the novel coronavirus.

Theres no evidence currently that there are new strains, Modjarrad cautioned. But the vaccine his team is developing would help researchers more quickly fight any mutated strains should they arise.

We have been vaccinating hundreds and hundreds of mice with different versions of our vaccine and we will be making the decision as to which one is the best one to take forward for manufacturing next week," Modjarrad said. "And then, ultimately, to a first-in-human clinical trial in the late summer.

Human data obtained from those trials will inform the advancement of the other vaccines being pursued by Operation Warp Speed, Modjarrad added.

Even though it will not be one of those first four vaccines that initially go into large scale testing, we believe that ... with coronavirus in general and not just this particular one, we may be onto something very good," Michael said.

Don't miss the top Army stories, delivered each afternoon

(please select a country) United States United Kingdom Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic of The Cook Islands Costa Rica Cote D'ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe

Subscribe

By giving us your email, you are opting in to the Army Times Daily News Roundup.

In mid-May, President Donald Trump announced that Operation Warp Speed would harness private sector partners and government agencies to deliver a COVID-19 vaccine by January 2021.

Modjarrad said the timeline handed down to deliver the vaccine is unprecedented but is very much possible." Historically, the time from when a new virus has been discovered to when a vaccine becomes available hasnt changed all that much over the past 150 years, he noted.

But what has changed is when there is a concerted and intentional effort to develop a vaccine when that vaccine program begins to when we get the vaccine that timeline has compressed considerably," Modjarrad added. "From decades to years, and now, potentially to months.

A vaccine for the new strain of the Zika virus that was recently circulating in the Western Hempishere, for instance, reached clinical trials in about eight months, said Modjarrad.

Other viruses, like HIV, have proven more difficult, depite the large amounts of funding and time since the virus was first identified in the 1980s.

But most viruses are not like HIV. They do not mutate like HIV, said Modjarrad. What youre seeing now, with us being able to compress the timeline, is us overcoming prior issues weve had with other vaccine development with funding and coordination.

Modjarrad said that the scientific community is learning about COVID-19 faster than just about any other virus that came before it, a fact he credited to the streamlined effort to find a vaccine.

How much of the vaccine will be produced and who it will be available to is unclear, but meeting the timeline for the end of the year should be possible, according to Col. Wendy Sammons-Jackson, director of the Military Infectious Disease Research Program.

It is reasonable to expect that there will be some form of a vaccine that could be available at some level, to a certain population by the end of the year," said Sammons-Jackson. As long as were able to continue to progress and learn and understand and adapt, I think we have all the resources available pointed in the same direction that could make that possible.

Read more here:

Army vaccine researchers are preparing for the possibility of new COVID-19 strains - ArmyTimes.com

Deacon tests positive for COVID-19 after Diocese of Savannah ceremony – WTOC

June 3, 2020

It wasnt open to the public, it was an invitation only event," explained Reverend Firmin. "So we were able to know everyone who was there. We actually had seating charts and there was space throughout the cathedral. We took every precaution that we needed plenty of hand sanitizer, rerouted the way we distributed communion even. We knew everyone who was there everyone has been notified and so were covering all our bases in that way.

Go here to see the original:

Deacon tests positive for COVID-19 after Diocese of Savannah ceremony - WTOC

Anthony Fauci on Covid-19 reopenings, vaccines, and ‘warp speed’ – STAT

June 1, 2020

Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, has seen the photos of bars packed with mask-less patrons. He was not impressed.

He was similarly unenthused about a decision by the biotech company Moderna to issue snippets of early data from the vaccine trial his agency has been conducting without waiting for fuller results.

That said, these days, Fauci sees reason for cautious optimism about Modernas vaccine, and others. The idea of having a vaccine by the end of the year is aspirational, but its certainly doable, he told STAT in a wide-ranging interview.

advertisement

One of the most visible faces of the U.S. response to the coronavirus pandemic, the NIAID director also acknowledged the world will have limited data on the new vaccines when they are deployed, and may have to balance the need to save lives with the possibility of some adverse events.

A transcript of the interview has been lightly edited for length and clarity.

advertisement

A lot of states are moving to open up really quickly, trying to get their economies back in gear. Weve seeing pictures of crowds on beaches and in other settings; many people arent wearing masks. Are you worried that were setting ourselves up for a boomerang effect in the next few weeks?

I certainly have sensitivity for the need of the public to start getting to some form of normalization, given that weve been through more than three months of a very difficult time. But its a big country and the dynamics of the outbreak are different from one part of the country to another. If people want to get out, theyve really got to gauge it with the level of the outbreak in their particular area.

When I see a situation where there is a region, a state, a city, a county where theres a considerable amount of viral activity there, and you see people crowding around bars and there were several pictures of that, that was quite striking over the last couple of days or on boardwalks, where theyre very, very close to each other, I do get concerned.

Lets talk about vaccines. In a recent interview with the Financial Times Merck CEO Ken Frazier effectively questioned the assertion which you have made that we could have Covid-19 vaccines within 12 to 18 months. Merck has a ton of experience developing vaccines. Are you at all worried that expectations for the timeline to vaccines have been set too high?

I am not really very concerned about the timetable of this for the following reasons.

The general trend on the part of the pharmaceutical companies, because of the enormous investment that goes into the development of a vaccine, is that you dont go to the next step until youre fairly certain that the step youre in is going to be successful. The other thing is you dont start manufacturing anything until you have a pretty good idea that you have a successful efficacy signal. That protracts out the time frame. But what were doing is something thats called developing at risk.

What it means is that at the same time youre finishing your Phase 1 trial, youre preparing your Phase 3 trial sites, which is very expensive, and then youre starting to manufacture the vaccine even before you know it works. All of that cuts months off.

Were now completing the Phase 1 [with the Moderna vaccine]. The initial data look very promising from the neutralizing antibody standpoint. And so theyre planning to start the Phase 3 in the first week or so of July. Not only with the Moderna vaccine, but also very likely with the AstraZeneca vaccine. And then as we get later into the summer, well get the Johnson & Johnson in clinical trials.

You need a few months at least of having vaccinated individuals getting exposed. So lets say its July, August, September, October. By November, you should have an efficacy signal.

If you do and youre already manufacturing doses, by December and January, if youre lucky and if in fact it is effective, you can have a significant number of doses available by the end of the year, the beginning of 2021. So I think its aspirational, but its certainly doable.

The only thing thats the big unknown to me is that, is it going to be effective? I think we could do it within the time frame that Ive outlined. But theres no guarantee that its going to be effective.

Lets talk a bit about what youve seen so far in terms of data. When Moderna recently released some the information on the vaccine they are developing with NIAID, they showed neutralizing antibodies in eight people. Are there more data? And what are the antibody levels like? Because they didnt give us any kind of scale against which we could assess what they were saying.

I know. I didnt like that. What we would have preferred to do, quite frankly, is to wait until we had the data from the entire Phase 1 which I hear is quite similar to the data that they showed and publish it in a reputable journal and show all the data. But the company, when they looked at the data, as all companies do, they said, wow, this is exciting. Lets put out a press release.

The thing that made everyone be cautiously optimistic is that we didnt just see binding antibody. It was clearly antibody that was neutralizing live virus, at levels that you would predict would be protective if in fact neutralizing antibody, which is a reasonable assumption, is going to be a correlate of immunity.

Have you been at all concerned about adverse events? They had some Grade 3s. [Grade 3 adverse events are serious, but not considered life-threatening.]

At the high dose. Of course, whenever you get adverse events at high doses, youre hoping that you can get the protective effect that you want at a dose thats considerably less than that. And it looks like we can. [Moderna has discontinued study of the highest dose.]

What about what youre seeing about the other vaccines in the clinic already? Do you think things are looking good for multiple vaccines to come through?

Well, the Oxford University vaccine [developed in partnership with AstraZeneca], the data in the animals, you know, some of the animals got infected. They didnt get sick. I would have liked to have had protection against infection. But then again, it depends on what youre looking for with the vaccine. That vaccine doesnt look like its a knockout for protecting against infection, but it might be really very good at protecting against disease. So I withhold judgment on that.

Youre asking me an opinion of things, but theres still little data. The Pfizer one is very similar to Modernas. Its an mRNA vaccine. Im sure that Pfizer is going to get results that are as good as the Moderna vaccine. Theres no reason to believe one is going to be any different than the other.

What I like about the whole thing is that there are multiple candidates that were involved with. It just feels good to be directly or indirectly involved in four or five candidates, to do it in a way that I refer to as sort of harmonized, where you come to an agreement, which we did, that were going to do things where the trial protocols will be quite similar, where the laboratory tests that were going to ask for are going to be quite similar, so that you can extrapolate results from one study to another.

Now, why is that important? If one vaccine proves efficacy in a clinical trial and another vaccine is behind it but its getting the same correlate of immunity you could bridge data and facilitate the approval of the second and the third one based on the efficacy of the first one.

You said vaccine could start to be administered in late December or January. Is that the time frame President Trump is looking for? It sounds like hes hoping for something sooner.

I think that the president and the administration would be really very happy if we had a vaccine that we could deploy by the end of this year.

Does the president talk to you about the vaccine work often?

No.

We used to have task force meetings every single day, including Saturday and Sunday, and about 75% of the time after the task force meeting wed meet with the president. So I was meeting with him four times a week back, a month or so ago.

But as you probably noticed, that the task force meetings have not occurred as often lately. And certainly my meetings with the president have been dramatically decreased.

With such a compressed timeline for testing the vaccines, how much do you think were actually going to know about them before we start to deploy them? If youre only getting a few months worth of data, we wont know much, if anything, about the durability of the protection. And, you know, we may not have a ton of information about efficacy or safety.

So when you design a clinical trial, there are a certain number of events that will give you a definitive answer as to whether or not your vaccine is effective. That is set in stone. So were not going to declare efficacy or even begin to think about efficacy or not until we reach that predetermine statistically sound number of infections that either occurred and/or were prevented. I mean, whether we do the trial over 10 years, or we do it over four months, the endpoint is still the same. Its certainly statistically significant difference. So I dont worry about that.

On durability,youreabsolutelycorrect.Werenotgoingtoknowwhatthedurability is. But were going to have to live with that. The first thing were interested in is: If we vaccinate you in the late summer, early fall, are you protected through that fall, that winter and then going into the spring? If the answer is yes, wonderful. Then well worry about durability.

And in terms of safety, you are facing the same thing. I mean, obviously, the concern with a vaccine, with a virus like this, is what are you going to get enhancing effect, [where the vaccine actually makes some recipients develop worse illness if they contract the infection]. Weve seen it with a couple of other viruses that we had reasonably good vaccines against, dengue and respiratory syncytial virus.

Weve designed the Phase 3 trial, to very carefully look at safety, even more so than is done in a regular trial.

Is a trial of 30,000 people large enough to see that kind of a signal if it exists?

Yeah, I think so. But then again, someone would say, appropriately, but what happens when you give it to 5 million people?

Or 5 billion?

And then if thats the case, then youve got to balance you balance the lives saved from the vaccine with the enhanced detrimental effect. So if for every one that has enhanced illness, you save a thousand lives, Ill take that, right?

Theres a lot of interest in developing vaccine as quickly as possible, but theres also a lot of concern about the speed at which this is being undertaken. Should there be major adverse events associated with use of these vaccines, it could really damage trust in vaccination in general. Is that something you are worrying about?

Yes, I am.

But I just realized that I have to phone into an Operation Warp Speed meeting. Im already late. Ill talk to you later.

More:

Anthony Fauci on Covid-19 reopenings, vaccines, and 'warp speed' - STAT

COVID-19 and the Class of 2020: Fairfax Co. graduate was forced into a big adjustment – WTOP

June 1, 2020

The COVID-19 pandemic has led to changes in a lot of people's lives. Andrea Darmawan, of Fairfax County's Robinson Secondary School, had to make a change of plans that will affect her next four years -- at least.

The second in a series by WTOPs Kate Ryan on local high school seniors and how theyre coping with the effects of the COVID-19 pandemic on the end of their school careers.

On one level, having to stay at home and take part in distance learning wasnt a big deal for Andrea Darmawan, 18, a senior at Robinson Secondary School in Fairfax County, Virginia: Im an introvert by nature, she said, so I have not been too upset, to be honest.

But it did have its challenges. For one, she said, I struggle with being productive at home, and the structure of being in school helped her stay focused.

The other challenge was that Darmawan is blind, and having software that could meet her needs was critical.

Darmawan said she was lucky: One teacher had the foresight to get all the blind and visually impaired students at our school together to test the software. They did find some bugs that would have made the software unusable. It could have been worse, she said with a laugh.

Like every high school senior, Darmawan dreamed of hearing Pomp and Circumstance at her graduation ceremony, crossing a stage and collecting her diploma.

WTOP's Kate Ryan talks with a senior at Robinson Secondary School in Fairfax County on the impact of the coronavirus outbreak.

She recalled in previous years watching livestreams of her friends graduations and thinking Oh my gosh, I cant wait to be that person! I cant wait to be up on that stage, and theyre going to be saying my name and theyre going to have everyone clapping for me and its going to be so great!

Then along came the coronavirus. And then it was, Oh well, nope.

COVID-19 and the Class of 2020

Graduation was scheduled for June 3, and there will be a photo opportunity for students, but Darmawan said, Its kind of anti-climactic, really.

For her, the effects of the pandemic could last well past high school: Her first-choice college was Emerson, in Boston, and she was accepted there. But she knew she needed to visit the school before enrolling, to determine whether it would be a good fit, especially from a logistical point of view.

The plan was to fly up with her mother and take advantage of an orientation. Thats when the coronavirus pandemic struck: Virginias stay-at-home order went into effect, and travel would mean a 14-day quarantine in Boston, which wasnt feasible.

So, the decision was made to attend the University of Mary Washington, in Fredericksburg, where shell study political science. And her future looks bright. She was thrilled to hear that the school plans on having classes on campus she wont have to settle for distance learning.

I need to be there, she said. Besides, having to pay for a college education but take lessons online negates the whole experience.

She said her teachers have prepared her to head off to college and have helped her push herself. One teacher, in particular, Ms. Bremer, nudged her out of my comfort zone.

She also described Mr. Ruiz and Ms. Marker as inspirational, passionate about their subjects and supportive of their students.

As a student with a disability, I always feel like Im kind of a burden, Darmawan said, because I have accommodations that teachers need to fulfill.

She said she felt supported at Robinson, but that wasnt always the case.

Darmawan was born in Indonesia, and attended school there for a year before coming to the United States.

I come from a country where people with disabilities dont have many rights, she said. Youre supposed to manage on your own.

Shes managing plenty as it is, as the coronavirus is directing a major part of the course of her life.The loss of her graduation and the change in her college plan are behind the advice she gives for others affected by the pandemic: Thats just the lesson I have, I guess: Just keep in mind that things arent always going to work out the way you imagined.

More:

COVID-19 and the Class of 2020: Fairfax Co. graduate was forced into a big adjustment - WTOP

What you need to know about the COVID-19 pandemic on 1 June – World Economic Forum

June 1, 2020

Responding to the COVID-19 pandemic requires global cooperation among governments, international organizations and the business community, which is at the centre of the World Economic Forums mission as the International Organization for Public-Private Cooperation.

Since its launch on 11 March, the Forums COVID Action Platform has brought together 1,667 stakeholders from 1,106 businesses and organizations to mitigate the risk and impact of the unprecedented global health emergency that is COVID-19.

The platform is created with the support of the World Health Organization and is open to all businesses and industry groups, as well as other stakeholders, aiming to integrate and inform joint action.

As an organization, the Forum has a track record of supporting efforts to contain epidemics. In 2017, at our Annual Meeting, the Coalition for Epidemic Preparedness Innovations (CEPI) was launched bringing together experts from government, business, health, academia and civil society to accelerate the development of vaccines. CEPI is currently supporting the race to develop a vaccine against this strand of the coronavirus.

1. How COVID-19 is affecting the globe

Number of confirmed COVID-19 cases reported in the last seven days by country, territory or area, 25 May to 31 May

Image: World Health Organization

2. Pope: People more important than the economyFor the first time in several months, Pope Francis addressed the public, stressing how countries should prioritize as they reopen.

Healing people, not saving (money) to help the economy (is important), healing people, who are more important than the economy, Francis said.

Pope Francis leads the Regina Coeli prayer from his window in the newly reopened St. Peter's Square after months of closure.

Image: Vatican Media via REUTERS

3. Britain eases lockdown, but is it too soon?

English schools reopened on Monday for the first time since they were shut 10 weeks ago, but many parents planned to keep children at home amid fears ministers were moving too fast.

Britain has one of the highest death rates from COVID-19, and many people are worried that it is happening too soon, including a number of scientists who advise the government who have warned it could lead to a second spike in infections.

4. Mythbusting can strengthen false beliefsCOVID-19 mythbusting may have had limited impact because familiarity can strengthen false beliefs, according to an article published by the Conversation. Studies have shown that people who have read 'myth vs fact' articles remember which items are true and which are false right after reading such pieces. But several days later, people can accept false ideas as true.

Facts: Earth is not flat; Moon is not cheese.

Image: The Conversation

A study by health economists finds that paid sick leave could help slow the spread of diseases such as coronavirus. The study examined mandates enacted by state and local governments in the US between 2005 and 2018. Their research found that workers were more likely to stay home when sick with such measures in place, helping to contain illness. Women and minorities, who often work in industries that don't traditionally offer paid sick leave particularly benefit.

COVID-19 brought many policies around the globe to prevent the virus' spread including policies such as the Families First Coronavirus Response Act in the US. That policy, which went into effect April 1 for small- and medium-sized small businesses, was the first congressionally-passed bill providing Paid Sick Leave for employees. Bills like that, wrote the researchers, will be key to containing the virus, especially as businesses reopen.

License and Republishing

World Economic Forum articles may be republished in accordance with our Terms of Use.

Written by

Linda Lacina, Digital Editor, World Economic Forum

The views expressed in this article are those of the author alone and not the World Economic Forum.

Read this article:

What you need to know about the COVID-19 pandemic on 1 June - World Economic Forum

State reports fewest new COVID-19 infections in more than two months – The Burg News

June 1, 2020

An image from the PA Department of Health lab in Exton

New COVID-19 diagnoses sank to their lowest level since late March today, with the state health department reporting fewer than 400 cases.

The PA Department of Health reported 356 new positive cases for the period ending at midnight.

This marks 22 days straight with new case numbers below 1,000 in Pennsylvania. With the additional cases, 72,282 Pennsylvanians have now been diagnosed with the coronavirus.

Cases peaked in early April at nearly 2,000 daily new cases. Since then, cases have shown a gradual, relatively steady decline, despite increasingly greater testing levels for the virus.

New case and fatality data has tended to be lower on weekends due to less reporting to the state health department.

Of the new cases reported today, 59 are in residents of nursing and personal care homes.

Locally, total diagnosed cases are as follows:

Overall, 15.6 percent of PA residents tested have shown to be positive for the virus.

The health department also reported another 12 fatalities, meaning that 5,567 Pennsylvanians have died from the disease since March. Not all of these deaths necessarily occurred in the past 24 hours, as the health department constantly updates its data.

Of the newly reported fatalities, most were residents of nursing or personal care homes.

Around central PA, the COVID-19 fatality data now stands as follows:

Statewide, Philadelphia County continues to have the most confirmed cases with 18,517 cases, followed by Montgomery County with 7,093 cases. The two counties also have reported the most deaths statewide from the disease: 1,320 and 686, respectively.

As Pennsylvania continues to move forward in the process to reopen, we need to remember that the threat from COVID-19 has not gone away, health Secretary Rachel Levine said.

So far, the state has moved 57 of Pennsylvanias 67 counties into the less restrictive yellow phase, including all of the Harrisburg area except Lancaster County. By June 5, the remainder of the state will exit from the red phase.

Nursing homes and personal care facilities have been particularly hard hit by the virus. Of total deaths, 3,557, or 63.9 percent, have occurred in residents from nursing or personal care facilities, according to the health department.

In nursing and personal care homes, there are 15,545 resident cases of COVID-19, and 2,663 cases among employees, for a total of 18,208 at 608 distinct facilities in 44 counties, according to the health department.

In addition, about 5,463 of total cases in PA are in health care workers.

Statewide, 461,713 coronavirus tests have been performed, with 389,431 people testing negative, according to the state health department. Yesterday, the state reported that 455,037 people had been tested for the virus.

Of the patients who have tested positive to date, the age breakdown is as follows, according to the health department:

Most of the patients hospitalized are 65 or older, as are most of the reported deaths, according to the state.

Levine continued to emphasize that Pennsylvanians should do the following:

As counties move into the yellow and green phases, we must take personal responsibility to protect others, Levine said. Wearing a mask, continuing to maintain social distancing, and washing your hands frequently are all steps we can take to help protect others, including our most vulnerable Pennsylvanians, our essential workers and our healthcare system.

For more information, visit the PA Department of HealthsCOVID-19 website.

Continued here:

State reports fewest new COVID-19 infections in more than two months - The Burg News

DHS: State has more than 6K active COVID-19 cases, 64% of patients have recovered – WSAW

June 1, 2020

The Wisconsin Department of Health Services reports the state currently has 6,109 active COVID-19 cases. That means 64% or 11,838 have recovered after contracting the virus.

In its latest daily data report update, three more patients have died; bringing the states total deaths to 595. The state also saw a lower than normal amount of test processedof the 3,632 tests processed, 140 more cases of COVID-19 were confirmed. Thats means 3.9% of all tests in the last 24 hours were positive.

To date, in central and north central Wisconsin Adams, Iron, Marathon, Waupaca and Wood counties have reported one death. Two deaths have been reported in Forest County. Four deaths have been reported in Clark County.

The state now has 56 labs processing tests. DHS also reported 31 more labs are being on boarded for future testing.

The percentage of hospitalized stayed the same day-to-day from Sunday. That means 14% of COVID patients were hospitalized for a total of 2,603.

As of Thursday, 253,595 have tested negative for COVID-19 and 18,543 have tested positive.

County case numbersCounties with new cases and/or deaths are in bold.

WisconsinAdams - 4 cases (1 death)Ashland - 2 casesBarron - 20 cases (+3)Bayfield - 3 cases (1 death)Brown - 2,320 cases (+1) (37 deaths)Buffalo - 6 cases (1 death)Burnett - 1 cases (1 death)Calumet - 77 cases (+1) (1 death)Chippewa - 56 casesClark - 33 cases (+1) (4 deaths)Columbia - 44 cases (1 death)Crawford - 26 casesDane - 735 cases (+5) (29 deaths)Dodge - 228 cases (+7) (2 death)Door - 38 cases (3 deaths)Douglas - 19 casesDunn - 24 casesEau Claire - 113 cases (+5)Florence - 2 casesFond du Lac - 214 cases (+1) (5 deaths)Forest - 29 cases (2 deaths)Grant - 96 cases (+1) (12 deaths)Green - 66 casesGreen Lake - 20 casesIowa - 16 casesIron - 2 cases (1 death)Jackson - 17 cases (1 death)Jefferson - 107 cases (+1) (3 deaths)Juneau 23 cases (1 death)Kenosha - 1,178 cases (+10) (30 deaths)Kewaunee - 35 cases (1 death)La Crosse - 53 casesLafayette - 27 casesLanglade - 3 casesLincoln - 7 casesManitowoc - 36 cases (1 death)Marathon - 50 cases (1 death)Marinette - 33 cases (2 deaths)Marquette - 4 cases (1 death)Menominee - 3 casesMilwaukee 7,799 cases (+44) (299 deaths)Monroe - 17 cases (1 death)Oconto - 37 casesOneida - 9 casesOutagamie - 230 cases (+3) (8 deaths)Ozaukee - 165 cases (+3) (12 deaths)Pepin - 1 casePierce - 45 casesPolk - 19 cases (1 death)Portage - 12 cases (+1)Price - 2 casesRacine - 1,733 cases (+11) (40 deaths) (+3)Richland - 14 cases (4 deaths)Rock - 639 cases (+3) (19 deaths)Rusk - 5 casesSauk - 78 cases (3 deaths)Sawyer - 8 casesShawano - 48 cases (+1)Sheboygan - 90 cases (3 deaths)St. Croix - 92 cases (+6)Taylor - 2 casesTrempealeau - 25 casesVernon - 21 casesVilas - 8 cases (+1)Walworth - 397 cases (+2) (17 deaths)Washburn - 2 casesWashington - 257 cases (+5) (7 deaths)Waukesha - 709 cases (+13) (30 deaths)Waupaca - 42 cases (+1) (1 death)Waushara - 8 casesWinnebago - 249 cases (+5) (7 deaths)Wood - 10 cases (1 death)

Continued here:

DHS: State has more than 6K active COVID-19 cases, 64% of patients have recovered - WSAW

Page 819«..1020..818819820821..830840..»